First Global WHO
Traditional Medicine Strategy
ACCESS
Statistics demonstrate overwhelmingly that it is the world’s poorest countries who are most in need of inexpensive, effective treatments for communicable diseases.
At the same time, access to modern essential chemical drugs is lowest
where people are suffering most from communicable diseases.
The reasons are well known and include inadequate financing and poor
health care delivery. In developing countries, however, TM can be comparatively
inexpensive.
Additionally, TM practitioners may be widely trusted and respected
providers of health care, albeit not necessarily officially recognized.
If access to TM is to be increased to help improve health status in
developing countries, however, several problems must be tackled.
Firstly, reliable standard indicators to accurately measure levels of access
— both financial and geographic —to TM must be developed.
Qualitative research to help identify constraints to extending access
should also be undertaken.
Secondly, the safest and most effective TM therapies
must be identified, to provide a sound basis for efforts to promote TM.
The focus should be on treatments for diseases that represent the
greatest burden for poor populations. This means focusing on the development of
antimalarials, and HIV/AIDS treatment and prevention.
Evidently, increasing access to safe and effective TM should not mean
displacing
programmes to increase access to allopathic medicine.
Rather opportunities to improve cooperation between TM practitioners and
allopathic medicine practitioners, should be created, to enable patients to
draw upon both TM and allopathic therapies to best meet their needs.
This is of course the case everywhere (and applies also to CAM).
But it is particularly
relevant in areas with poor access to allopathic medicine.
Fortunately, in these
areas, TM practitioners tend to be well established and well respected.
Working with these
practitioners can facilitate effective dissemination of important health messages
to communities, as well as promotion of safe TM practices.
If access to TM is to be
increased sustainably, the natural resource base upon which it often depends
must be sustained.
Raw materials for herbal medicines, for instance, are often
collected from wild plant populations.
Over-harvesting due to
intensified local use or to meet export demand is a growing problem.
http://whqlibdoc.who.int/hq/2002/WHO_EDM_TRM_2002.1.pdf
No comments:
Post a Comment